Thursday, July 9, 2026

pharma · PTIX

Protagenic Therapeutics, Inc.new

Protagenic Therapeutics, Inc.new clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

NEW YORK, NY, USA HQ
1 Employees
Public company Type
PTIX · NYSE Ticker
Company details
Status
Public
HQ
NEW YORK, NY, USA
Employees
1
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Programs

Protagenic Therapeutics, Inc.new projects

0 ClinicalTrials.gov programs sponsored by Protagenic Therapeutics, Inc.new.

Protagenic Therapeutics, Inc.new has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Protagenic Therapeutics, Inc.new have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.